US Edition
GPs can prescribe weight loss jabs on the NHS from today - but strict eligibility criteria in place
ENGLAND, JUN 23 – GPs in England can now prescribe Mounjaro to severely obese patients with multiple health issues, with around 220,000 expected to receive it in the first three years under strict NHS criteria.
- Starting Monday June 23, GPs in England can prescribe the weight loss injection Mounjaro to eligible patients on the NHS for the first time.
- This rollout follows previous restrictions where weight loss drugs were accessed only via specialist services or private prescriptions, amid rising obesity levels affecting 29% of UK adults.
- The programme targets about 220,000 people with a BMI over 40 plus at least four obesity-related health issues, while recognising GPs face workload and training challenges in managing this care.
- Health Secretary Wes Streeting highlighted that obesity is a major contributor to poor health and places a significant financial burden on the NHS, and the government plans to make advanced treatments accessible to all, not just those who can pay.
- The rollout emphasizes combining medication with lifestyle changes and prevention, while many patients may still seek private prescriptions due to initial NHS supply limits.
36 Articles
36 Articles
Mounjaro becomes available on the NHS: what to know and what to do if you’re not eligible
bigshot01/ShutterstockObesity remains one of the most pressing, and preventable, health challenges of our time. The UK is one of a number of countries undoubtedly struggling with it. It affects nearly every organ system in the body, contributing to cardiovascular conditions like coronary heart disease; musculoskeletal issues such as osteoarthritis and gout; and even the development of certain cancers, including of the breast, uterus and colon. I…
Mounjaro: Britons warned of 'very common' side effects as weight loss drug sees mass NHS rollout - including nausea & vomiting
In a major milestone for slimmers, the NHS has begun its mass rollout of the weight-loss drug Mounjaro, with GPs able to prescribe the medication for the first time
As of Monday, June 23, these treatments that have revolutionized the management of the disease can be prescribed by general practitioners. Who are they addressing, are they effective, what side effects? "Libé" takes stock.
Who can access the new Mounjaro weight loss jab on the NHS?
The NHS has begun a mass rollout of weight loss jabs in England, with GPs allowed to prescribe the medicine for the first time.Over the next 12 years through NHS primary care providers, 1.6 million people are expected to receive tirzepatide, a weight loss drug sold under the brand name Mounjaro.The drug was initially produced and licensed for type 2 diabetes by American pharmaceutical giant Eli Lilly. The drug reduced the appetite for patients m…
'King Kong' of weight loss jabs Mounjaro available on NHS to those in need from TODAY - The Mirror
Around 220,000 people with "greatest need" are expected to receive Mounjaro, also known as tirzepatide and made by Lilly through the NHS over the next three years
Coverage Details
Bias Distribution
- 59% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
